Come up with a name for your new list and we'll add to it:
Actinobac Biomed raised a round of funding on March 28, 2013. Investors include
National Institutes of Health.
Actinobac Biomed is a biopharmaceutical company developing therapeutics for multiple indications, including blood cancers, autoimmune/inflammatory diseases, and HIV. Its drug candidates are based upon…